Kidney disease complicates pancreatic surgery: new study aims to improve outcomes
NCT ID NCT07405099
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examines how end-stage renal disease (ESRD) impacts recovery after pancreatic surgery. Researchers will review medical records of 100 patients to compare complication rates, hospital stays, and costs based on kidney function and dialysis use. The goal is to provide clearer treatment recommendations for this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could lead to better, more personalized treatment plans for people with kidney disease who need pancreatic surgery.
What could go wrong
This is a small, observational study that only looks back at past cases, so it cannot prove cause and effect. Results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.